Dymon Asia Capital Singapore PTE. LTD. Sells 3,000 Shares of Danaher Corporation $DHR

Posted by on Jun 14th, 2026

Dymon Asia Capital Singapore PTE. LTD. reduced its position in Danaher Corporation (NYSE:DHR – Free Report) by 37.5% during the fourth quarter, HoldingsChannel reports. The firm owned 5,000 shares of the conglomerate’s stock after selling 3,000 shares during the period. Dymon Asia Capital Singapore PTE. LTD.’s holdings in Danaher were worth $1,145,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of DHR. Sivia Capital Partners LLC boosted its stake in shares of Danaher by 6.3% in the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after purchasing an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC boosted its stake in shares of Danaher by 40.2% in the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after purchasing an additional 886 shares during the last quarter. Ieq Capital LLC boosted its stake in shares of Danaher by 64.2% in the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC boosted its stake in shares of Danaher by 30.7% in the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Down 0.5%

Shares of NYSE DHR opened at $179.95 on Friday. The firm has a market cap of $127.37 billion, a PE ratio of 34.81, a P/E/G ratio of 2.40 and a beta of 0.81. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company’s fifty day simple moving average is $180.93 and its 200 day simple moving average is $204.78. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. Danaher’s revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.88 earnings per share. As a group, sell-side analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

More Danaher News

Here are the key news stories impacting Danaher this week:

Wall Street Analyst Weigh In

A number of research firms have recently commented on DHR. JPMorgan Chase & Co. reduced their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Morgan Stanley cut their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. TD Cowen cut their target price on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Barclays cut their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Piper Sandler began coverage on shares of Danaher in a research note on Thursday. They set a “neutral” rating and a $200.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $233.61.

Get Our Latest Report on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.